Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2654 |
|
| Actual shortage: | 249 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2396 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
26 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2021-04-21 | 2021-05-20 | 137890 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-01-20 | 2022-04-21 | 153156 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-02-17 | 2022-03-24 | 155155 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-11-14 | 2023-01-12 | 174595 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-01-12 | 2023-10-06 | 180891 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-06-16 | 2023-07-05 | 195219 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2023-06-20 | 2023-10-19 | 195806 |
| DULOXETINE DR | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-03-16 | 2018-11-08 | 43119 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2018-12-04 | 2019-08-06 | 68608 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92180 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2021-02-05 | 2021-03-11 | 133445 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-02-17 | 2023-04-28 | 185077 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-06-08 | 2023-10-03 | 194144 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-06-20 | 2023-07-05 | 195784 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2023-10-19 | 2023-11-30 | 207533 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1691 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1694 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-09-12 | 2020-03-16 | 61368 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68626 |
| ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68629 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| ACT DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
| ACT DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
| ACT DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
| ACT DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
| ACT DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 |